C1-Esterase Inhibitor in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia

Summary

Routine coagulation tests and measurement of the plasma levels of C1-esterase inhibitor (C1-INH) and antithrombin III were performed in 17 women with mild preeclampsia, 10 women with moderate preeclampsia and 20 women with uncomplicated pregnancy. All pregnant probands were within the third trimester of pregnancy. 20 non-pregnant women were used as controls. The gfoups were matched in age and the pregnant ones were also matched in gestational age.

C1-INH activity and antigen were significantly reduced (p <0.002) in normally pregnant women as compared with nonpregnant ones. Further, CI-INH activity was lower in women with mild preeclampsia and significantly lower in women with moderate preeclampsia (p <0.05) as compared with normally pregnant women. None of the plasmatic coagulation tests was indicative of a consumption reaction. We conclude that C1-INH activity and antigen reductions are commonly associated with pregnancy. Furthermore, as markedly lower values can be found in mild and moderate preeclampsia, measurement of the C1-INH activity in pregnant women within the third trimester might proof useful to establish the diagnosis of a preeclamptic condition.

• References

• 1 Inglis TCM, Stuart J, George AJ, Davies AJ. Haemostatic and rheological changes in normal pregnancy and pre-eclampsia. Br J Haematol 1982; 50: 461-465
• 2 Condie RG, Ogston D. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol 1967; 83: 938-942
• 3 Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12: 141-154
• 4 Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemostas 1984; 52 (02) 176-182
• 5 Estelles A, Gilabert J, Espana F, Aznar J, Gomez-Lechon MJ. Fibrinolysis in pre-eclampsia. J Fibrinolysis 1987; 1: 209-214
• 6 Aznar J, Gilabert J, Estelles A, Espana F. Fibrinolytic activity and protein C in preeclampsia. Thromb Haemostas 1986; 55 (03) 314-317
• 7 Gaffney PJ, Creighton LJ, Callus M, Thorpe R. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions. Br J Haematol 1988; 68 (01) 91-96
• 8 Borok Z, Weitz J, Owen J, Auerbach M, Nossel HL. Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia. Blood 1984; 63 (03) 525-531
• 9 Hopmeier P, Halbmayer M, Schwarz HP, Heuss F, Fischer M. Protein C and protein S in mild and moderate preeclampsia. Thromb Haemostas 1987; 58 (02) 794-795
• 10 Gow L, Campbell DM, Ogston D. Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol 1983; 90: 950-952
• 11 Armstrong NPI, Teisner B, Redman CWG, Westergaard JG, Folkersen J, Grudzinskas JG. Complement activation, circulating protease inhibitors and pregnancy-associated proteins in severe preeclampsia. Br J Obstet Gynaecol 1986; 93: 811-814
• 12 Hustin J, Foldart JM, Lambotte R. Maternal vascular lesions in preeclampsia and intrauterine growth retardation: light microscopy and immunfluorescence. Obstet Gynecol Surv 1985; 40: 145-149
• 13 Holzner JH. Pathology of the placenta in gestosis. In: Dilemmas in Gestosis Janisch H, Reinold E. (eds). Thieme; Stuttgart: 1983: 82-87
• 14 Weenink GH, Treffers PE, Vijn P, Smorenberg-Schoorl ME, Ten Cate JW. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol 1984; 148: 1092-1097
• 15 Trofatter Jr KF, Howell ML, Greenberg CS, Hage ML. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia. Obstet Gynecol 1989; 73: 435-440
• 16 Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravas-cular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. Gynecol Obstet Invest 1987; 24 (03) 170-178
• 17 Forbes CD, Pensky J, Ratnoff OD. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum Cl inactivator. J Lab Clin Med 1970; 76: 809-815
• 18 Schreiber AD, Kaplan AP, Austen KF. Inhibition by C1-INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest 1973; 52: 1402-1409
• 19 Pixley RA, Schmaier A, Colman RW. Effect of negatively charged activating compounds on inactivation of factor XIIa by C1 inhibitor. Arch Biochem Biophys 1987; 256 (02) 490-498
• 20 Lammle B, Berrettini M, Griffin JH. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen. Semin Thromb Hemostas 1987; 13 (01) 106-114
• 21 Goecke C, Schwabe G. Vorschlag einer Stadieneinteilung der Gestose. Zbl Gyn 1965; 42: 1439
• 22 Kemeter P, Friedrich F. Die Endokrinologie der Schwangerschaft. In: Klinik der Frauenheilkunde und Geburtshilfe. Vol. I. Doderlein G, Wulf KH. (eds). Urban and Schwarzenberg, Munich 1977; Addendum: 1978: 219-60/31
• 23 Mancini G, Carbonara AT, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235-238
• 24 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestim-mung des Fibrinogens. Acta Haematol 1957; 17: 237-246
• 25 Harpel PC. Blood proteolytic enzyme inhibitors: Their role in modulating blood coagulation and fibrinolytic enzyme pathways. In: Haemostasis and Thrombosis-Basic Principles and Clinical Practice Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds). JB Lippincott Comp; Philadelphia, PA: 1982: 738
• 26 Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6: 65-70
• 27 Nowotny Ch, Thaler E, Lechner K, Altmann P. Changes of coagulation in gestosis. In: Dilemmas in Gestosis Janisch H, Reinold E. (eds). Thieme; Stuttgart: 1983: 117-120
• 28 Schmaier AH, Schapira M, Colman RW. Methods to study the proteins of the contact phase of coagulation. Methods Haematol 1983; 7: 24-47
• 29 Gigli J, Mason JW, Colman RW, Austen KF. Interaction of plasma kallikrein with Cl inhibitor. J Immunol 1970; 104 (03) 574-581
• 30 Nilsson T. On the interaction between human plasma kallikrein and C1-esterase inhibitor. Thromb Haemostas 1983; 49 (03) 193-195
• 31 Lewis GP. Kinins in inflammation and tissue injury. In: Handbook of Experimental Pharmacology. In: Erdos EG. (ed). Springer-Verlag; New York: 1970: 516-530
• 32 Derkx FHM, Schalekamp MPA, Bouma B, Kluft C, Schalekamp MADH. Plasam kallikrein-mediated activation of the renin-angio-tensin system does not require prior acidification of prorenin. J Clin Endocrinol Metab 1982; 54: 343-348
• 33 Nuijens JH, Huijbregts CCM, Eerenberg-Belmer AJM, Abbink JJ, Strack van Schijndel RJM, Felt-Bersma RJF, Thijs LG, Hack CE. Quantification of plasma factor XIIa-C1-inhibitor and kallikrein-C1-inhibitor complexes in sepsis. Blood 1988; 72 (06) 1841-1848
• 34 Stirrat GM, Redman CWG, Levinsky RJ. Circulating immuncom-plexes in pre-eclampsia. Br Med J 1987; 1: 1450-1451
• 35 Petrucco OM. Immunofluorescent studies in renal biopsies in preeclampsia. Br Med J 1974; i 473
• 36 Arias F, Mancilla-Jiminez R. Hepatic fibrinogen deposits in preeclampsia. N Engl J Med 1976; 295: 578
• 37 Kitzmiller JL, Benirschke K. Immuno-fluorescent study of placental bed vessels in preeclampsia of pregnancy. Am J Obstet Gynecol 1973; 115: 248
• 38 Faulk WP, Jeanet N, Creighton WD, Carbonara A. Immunological studies of the human placenta. J Clin Invest 1974; 54: 1011-1017
• 39 Massobrio M, Benedetto C, Bertini E, Tetta C, Camussi G. Immune complexes in preeclampsia and normal pregnancy. Am J Obstet Gynecol 1985; 152: 578-583
• 40 Bartl W, Riss P, Knapp W. Evaluation and the prognostic value of freely circulating immune complexes in EPH-gestosis. In: Dilemmas in Gestosis Janisch H, Reinold E. (eds). Thieme; Stuttgart: 1983: 68-71
• 41 Howert-de-Jong MH, Te Velde ER, Nefkens MJJ, Schuurman HJ. Immune complexes in skin of patients with pre-eclamptic toxaemia. Lancet 1982; ii 387
• 42 Schena FP, Selvaggi L, Pastore A, Germinario C, Loverro G, Bettocchi S. The role if immune complexes (IC) in EPH-gestosis. A dilemma in gestosis. In: Dilemmas in Gestosis Janisch H, Reinold E. (eds). Thieme; Stuttgart: 1983: 65-66
• 43 Gleicher N, Theofiopopoulos AN, Bears P. Immune complexes in pregnancy. Lancet 1978; i 1108
• 44 Knox GE, Stagno S, Volanakis JE, Huddleston JF. A search for antigen-antibody complexes in pre-eclampsia: Further evidence against immunologic pathogenesis. Am J Obstet Gynecol 1978; 132: 87-89
• 45 Balasch J, Mirapeix E, Borche L, Vives J, Gonzales-Merlo J. Further evidence against preeclampsia as an immune complex disease. Obstet Gynecol 1981; 55: 435-437
• 46 Westergaard JG, Svehag S-E, Hau J, Teisner B. Quantitative comparison of circulating immune complexes in normal pregnancy and pregnancy related hypertension. Acta Obstet Gynecol Scand 1986; 65: 181-182
• 47 Jespersen J, Kluft C. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen-levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and Cl-inactivator. Thromb Haemostas 1985; 54 (02) 454-459
• 48 Gordon EM, Ratnoff OD, Saito H, Donaldson VH, Pensky J, Jones PK. Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased Cl esterase inhibitor titers in women taking oral contraceptives. J Lab Clin Med 1980; 96 (03) 762-769
• 49 Bockers M, Bork K. Kontrazeption und Schwangerschaft beim hereditaren Angioodem. DMW 1987; 112 (13) 507-509
• 50 Tietz NW, Saunders WB. (eds). Textbook of Clinical Chemistry. 1986
• 51 Cohen SH, Koethe SM, Kozin F, Rodey G, Arkins JA, Fink JN. Acquired angioedema associated with rectal carcinoma and its response to danazol therapy. J Allergy Clin Immunol 1978; 62: 217-221
• 52 Frigas E. Angioedema with acquired deficiency of the Cl inhibitor: A constellation of syndromes. Mayo Clin Proc 1989; 64: 1269-1275
• 53 Falus A, Feher KG, Walcz E, Brozik M, Fust G, Hidvegi T, Feher T, Meretey K. Hormonal regulation of complement biosynthesis in human cell lines I. Androgens and gamma interferon stimulate the biosynthesis and gene expression of Cl inhibitor in human cell lines U937 and HEPG2. Mol Immunol 1990; 27 (02) 191-196
• 54 Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal I, Blankstein J, Goldman B, Mashiach S. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321 (06) 351-356
• 55 Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, Gastaldi A, Remuzzi G. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321 (06) 357-362
• 56 Rao AK, Schapira M, Niewiarowski S, Budzynski A, Schmaier A, Mills D, Willis J, Beckett C, James A, Silver L, Scott C, James P, Harris M, Kieve C, Clements ML, Levine M, Hughes T, Black R, Colman RW. Prospective study of hemostatic systems during mild Rocky Mountain spotted fever. Clin Res 1982; 30: 328A
• 57 Yamada T, Harber P, Pettit GW, Wing DA, Oster CN. Activation of the kallikrein-kinin system in Rocky Mountain spotted fever. Ann Intern Med 1978; 88: 764-768
• 580 Colman RW, Edelman R, Scott CF, Gilman RH. Plasma kallikrein activation and inhibition during typhoid fever. J Clin Invest 1978; 61: 287-296
• 59 Mason JW, Kleeberg U, Dolan P, Colman RW. Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann Intern Med 1970; 73: 545-551
• 60 O’Donnell Jr TF, Clowes Jr GHA, Colman RW. Kinin activation in the blood of patients with sepsis. Surg Gynecol Obstet 1976; 143: 539-545
• 61 Carvalho AC, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290: 434-438
• 62 Carvalho AC, Lees RS, Vaillancourt RA, Colman RW. Effect of clofibrate on intravascular coagulation in hyperlipoproteinemia. Circulation 1977; 56: 114-118
• 63 Lange LG, Carvalho AC, Bagdasarian A, Lahiri B, Colman RW. Activation of Hageman factor in the nephrotic syndrome. Am J Med 1974; 56: 565-569
• 64 Kallen RJ, Soo-Kwang L. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome. Pediatr Res 1975; 9: 705-709
• 65 Wong PY, Talamo RC, Babior BM, Raymond GG, Colman RW. Kallikrein-kinin system in postgastrectomy dumping syndrome. Ann Intern Med 1974; 80: 577-581
• 66 Mason JW, Colman RW. The role of Hageman factor in disseminated intravascular coagulation induced by sepsis, neoplasia or liver disease. Thromb Diath Haemorrh 1971; 26: 325-331
• 67 Philapitsch A, Murday H, Popov-Cenic S. Das Kallikreinsystem: Aktivierungs- und Inhibitionspotential wahrend des extrakorporalen Kreislaufes in einer Placebo-Aprotinin-Cl-Inhibitor-Studie. In: Pro-teolyse und Proteinaseninhibition in der Herz- und GefaBchirurgie Dudziak R, Kirchhoff PG, Reuter HD, Schumann F. (eds). Schattauer, Stuttgart: 1985: 201-208
• 68 Hentges F, Humbel R, Dicato M, Hemmer R, Kuntziger H. Acquired Cl esterase-inhibitor deficiency: Case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestations. J Allergy Clin Immunol 1986; 78: 860-867
• 69 Rodriguez M, Ancochea J, De Buen C, Merino JL, Marques G, Vivanco F. Acquired Cl-inhibitor deficiency associated with a lupuslike anticoagulant activity. Ann Allergy 1988; 61: 348-350
• 70 Jackson J, Feighery C. Autoantibody-mediated acquired deficiency of Cl inhibitor. N Engl J Med 1988; 318: 122-123
• 71 Jackson J, Sim RB, Whelan A, Feighery C. An IgG autoantibody which inactivates Cl-inhibitor. Nature 1986; 323: 722-724
• 72 Alsenz J, Bork K, Loos M. Autoantibody-mediated acquired deficiency of Cl inhibitor. N Engl J Med 1986; 316: 1360-1366
• 73 Pascual M, Widman J-J, Schifferli JA. Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia. Am J Med 1987; 83: 959-962
• 74 Gelfand JA, Boss GR, Lockard ConleyC, Reinhart R, Frank MM. Acquired Cl esterase inhibitor deficiency and angioedema: A review. Annu Rev Med 1979; 58 (04) 321-328
• 75 Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldson VH. Genetically determined herterogeneity of the Cl esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 1971; 50: 2143-2149
• 76 Donaldson VH, Harrison RA, Rosen FS, Bing DH, Kindness G, Canar J, Wagner CJ, Awad S. Variability in purified dysfunctional Cl-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies. J Clin Invest 1985; 75: 124-132